XK
CLB icon

Xact Kapitalforvaltning’s Core Laboratories CLB Stock Holding History

Xact Kapitalforvaltning’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-3,906
Closed -$386K – 1322
2017
Q3 		$386K Hold
3,906
– – 0.01% 615
2017
Q2 		$396K Buy
3,906
+1,200
+44% +$129K 0.01% 622
2017
Q1 		$313K Hold
2,706
– – 0.01% 627
2016
Q4 		$325K Sell
2,706
-8
-0.3% -$886 0.01% 624
2016
Q3 		$305K Buy
+2,714
New +$313K 0.01% 614

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Xact Kapitalforvaltning's CLB Position: Q4 2017 in Review

Xact Kapitalforvaltning sold out of Core Laboratories (CLB) in Q4 2017, closing a stake of 3,906 shares — an estimated $386K sold.

Xact Kapitalforvaltning first reported a position in CLB in Q3 2016 and held it in 5 quarters. The position peaked at $396K in Q2 2017. 356 funds tracked by Wall St. Rank hold CLB as of Q4 2017.

  • Xact Kapitalforvaltning reported no remaining Core Laboratories position as of Q4 2017 after selling out during the quarter.
  • Xact Kapitalforvaltning sold 3,906 Core Laboratories shares in Q4 2017, an estimated $386K.
  • Xact Kapitalforvaltning first reported a position in Core Laboratories in Q3 2016 and held it in 5 quarters.
  • Xact Kapitalforvaltning's Core Laboratories position peaked at $396K in Q2 2017.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2017.

Based on Xact Kapitalforvaltning's 13F filing for Q4 2017, filed 8 Feb 2018.